T cell regulation by adult prostate stem cells
成体前列腺干细胞对 T 细胞的调节
基本信息
- 批准号:10382302
- 负责人:
- 金额:$ 18.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-02 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:5 Alpha-Reductase InhibitorAddressAdrenergic alpha-AntagonistsAdultAffectAgeAntigensApoptosisAutoimmuneBasal CellBehaviorBenign Prostatic HypertrophyBiological AssayBiological ProcessCD8-Positive T-LymphocytesCD8B1 geneCell physiologyCellsChronicCoupledDataDevelopmentDiseaseEpithelialEvaluationExhibitsFluorescence-Activated Cell SortingFoundationsFrequenciesFunctional disorderGenesGranzymeGrowth FactorHarvestHomeostasisHumanHyperplasiaImmuneImmune TargetingImmunologic Suppressor FactorsIn VitroIncidenceIncontinenceInflammationInflammatoryInvestigationLightMediatingMesenchymal Stem CellsModelingMusMyeloid-derived suppressor cellsNitric OxideNocturiaNoduleOperative Surgical ProceduresOvalbuminPECAM1 genePTPRC genePathologicPathway interactionsPatientsPlayPopulationPrevalenceProductionProliferatingProstateProstatic DiseasesProstatic hypertrophyQuality of lifeRegulator GenesResistanceRoleSamplingSampling StudiesStromal HyperplasiaT cell anergyT cell regulationT cell responseT-Cell ProliferationT-LymphocyteTissuesTransgenic OrganismsTumor-infiltrating immune cellsUrethraanergyautoimmune inflammationcancer initiationcell killingcytokinedifferential expressiondisabling symptomepithelial stem cellexhaustionexperimental studyimmunoregulationimprovedin vivoinflammatory milieumale healthmenmicturition urgencymouse modelnovelprogenitorprogrammed cell death ligand 1prostatitissingle cell mRNA sequencingsingle-cell RNA sequencingstemstem cell populationstem cellstargeted treatment
项目摘要
Project summary/abstract:
Adult prostate stem cells (PSC) are a rare epithelial progenitor population in the prostate. While essential for
normal homeostasis, they have also been implicated in hyperplasia and cancer initiation.1-7 Inflammation can
fuel hyperplastic diseases through its production of growth factors and cytokines;1, 8, 9 however, the impact of
inflammatory factors on PSC and how PSC interact with infiltrating immune cells is not well studied. To examine
the cross-talk between epithelial PSC and immune cells, the proposed studies will utilize the Prostate Ovalbumin
Expressing Transgenic 3 (POET3), an inducible mouse model of abacterial T cell induced inflammation that
produces epithelial and stromal hyperplasia, functioning as a model for human autoimmune prostatitis.10
Current studies in our lab have taken prostates from inflamed and non-inflamed (naïve) POET3 mice, which
were harvested, digested, and separated by fluorescence-activated cell sorting (FACS) to isolate an enriched
basal PSC population defined as lineage negative (CD45-/CD31-), stem cell antigen-1+, CD49f+ (LSC).11, 12 Single
cell mRNA sequencing comparing freshly isolated LSC from naïve (nLSC) and inflamed (iLSC) mice revealed
differential expression of multiple immune regulatory genes, suggesting a possible role in regulating T cell
response. In vitro suppression assays conducted in our lab confirmed that while neither mature luminal nor nLSC
impacted T cell proliferation, iLSC were able to suppress CD8+ T cells. This effect is independent of recognized
mechanisms, nitric oxide production, IDO1, or PD-L1.13 Notably, prostates from inflamed mice show a marked
enrichment for LSC, suggesting that these cells are protected from T cell attack. Coupled with human BPH data
indicating prominent T cell populations enriched for exhaustion and anergy genes, these findings suggest a
potential novel mechanism of T cell suppression not previously identified in LSC that is induced under
inflammatory conditions, possibly as a tissue protective mechanism.
Thus, we hypothesize that adult basal prostate stem cells are able to harness immune regulatory capabilities
to suppress T cell function and survive T cell mediated attack. Using the POET3 model of autoimmune
inflammation and human BPH samples, studies described herein will explore the T cell suppressive factors
utilized by PSC in vitro and evaluate the impact of PSC suppression in vivo.
The resulting data will provide a foundation for more thorough study of rare stem/progenitor cells in immune
regulation while shedding light on their contribution to epithelial hyperplasia during inflammation.
项目概要/摘要:
成体干细胞 (PSC) 是前列腺中罕见的上皮祖细胞群,同时也是前列腺所必需的。
正常的体内平衡,它们也与增生和癌症发生有关。1-7 炎症可以
通过产生生长因子和细胞因子加剧增生性疾病;1, 8, 9 然而,
PSC 上的炎症因子以及 PSC 如何与浸润性免疫细胞相互作用尚未得到充分研究。
上皮 PSC 和免疫细胞之间的串扰,拟议的研究将利用前列腺卵清蛋白
表达转基因 3 (POET3),一种非细菌 T 细胞诱导炎症的诱导型小鼠模型,
产生上皮和基质增生,作为人类自身免疫性前列腺炎的模型。 10
我们实验室目前的研究已经从发炎和非发炎(幼稚)POET3 小鼠身上采集了前列腺,
收获、消化并通过荧光激活细胞分选 (FACS) 分离,以分离出富集的
PSC 群体定义为谱系阴性 (CD45-/CD31-)、干细胞抗原 1+、CD49f+ (LSC)。11、12 单
细胞 mRNA 测序比较了来自幼稚 (nLSC) 和炎症 (iLSC) 小鼠的新鲜分离的 LSC
多个免疫调节基因的差异表达,表明可能在调节 T 细胞中发挥作用
我们实验室进行的体外抑制试验证实了这一点,而成熟的 luminal 和 nLSC 都没有。
影响 T 细胞增殖,iLSC 能够抑制 CD8+ T 细胞,这种作用与公认的无关。
机制、一氧化氮产生、IDO1 或 PD-L1.13 值得注意的是,发炎小鼠的前列腺显示出明显的
结合人类 BPH 数据,表明这些细胞免受 T 细胞攻击。
表明显着的 T 细胞群富含疲劳和无反应基因,这些发现表明
之前在 LSC 中未发现的 T 细胞抑制的潜在新机制,该机制是在以下条件下诱导的
炎症状况,可能作为一种组织保护机制。
因此,我们追求成人基底前列腺干细胞能够利用免疫调节能力
使用 POET3 自身免疫模型抑制 T 细胞功能并在 T 细胞介导的攻击中存活。
炎症和人类 BPH 样本,本文描述的研究将探索 T 细胞抑制因子
PSC 体外利用并评估体内 PSC 抑制的影响。
由此产生的数据将为更深入地研究免疫中稀有干/祖细胞提供基础
调节,同时揭示它们在炎症过程中对上皮增生的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy L. Ratliff其他文献
Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device
- DOI:
10.1039/c6lc01279e - 发表时间:
2016-12 - 期刊:
- 影响因子:6.1
- 作者:
Wanfeng Huang;Chun-Li Chang;Norman D. Brault;Onur Gur;Zhe Wang;Shadia I. Jalal;Philip S. Low;Timothy L. Ratliff;Roberto Pili;Cagri A. Savran - 通讯作者:
Cagri A. Savran
Failure of intravesical interferon-alfa-2b for the treatment of patients with superficial bladder cancer previously failing intravesical BCG Therapy.
膀胱内注射干扰素-α-2b 治疗先前膀胱内卡介苗治疗失败的浅表性膀胱癌患者失败。
- DOI:
10.1016/1078-1439(95)00039-k - 发表时间:
1995-05-01 - 期刊:
- 影响因子:0
- 作者:
M'Liss A. Hudson;Timothy L. Ratliff - 通讯作者:
Timothy L. Ratliff
Inhibition of peritoneal tumor-cell implantation: model for laparoscopic cancer surgery.
腹膜肿瘤细胞植入的抑制:腹腔镜癌症手术模型。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:2.7
- 作者:
David S. Goldstein;Michael L. Lu;Tomotaka Hattori;Timothy L. Ratliff;Kevin R. Loughlin;L. Kavoussi - 通讯作者:
L. Kavoussi
Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis.
实验性自身免疫性膀胱炎:溃疡性间质性膀胱炎的潜在小鼠模型。
- DOI:
10.1016/s0022-5347(17)37091-x - 发表时间:
1992-12-01 - 期刊:
- 影响因子:0
- 作者:
Arnold D. Bullock;Arnold D. Bullock;M. J. Becich;M. J. Becich;C. Klutke;C. Klutke;Timothy L. Ratliff;Timothy L. Ratliff - 通讯作者:
Timothy L. Ratliff
Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
膀胱内卡介苗治疗浅表性膀胱癌:卡介苗活力对治疗结果的影响。
- DOI:
- 发表时间:
1985 - 期刊:
- 影响因子:6.6
- 作者:
D. R. Kelley;Timothy L. Ratliff;W. Catalona;Amos Shapiro;Janice M. Lage;Walter C. Bauer;E. Haaff;S. Dresner - 通讯作者:
S. Dresner
Timothy L. Ratliff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy L. Ratliff', 18)}}的其他基金
Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
- 批准号:
10218167 - 财政年份:2020
- 资助金额:
$ 18.81万 - 项目类别:
Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
- 批准号:
10439754 - 财政年份:2020
- 资助金额:
$ 18.81万 - 项目类别:
Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
- 批准号:
10655549 - 财政年份:2020
- 资助金额:
$ 18.81万 - 项目类别:
Use of Micro-RNA Arrays to Identify MDSC Functional Pathways and Markers
使用 Micro-RNA 阵列识别 MDSC 功能途径和标记
- 批准号:
8451031 - 财政年份:2013
- 资助金额:
$ 18.81万 - 项目类别:
Use of Micro-RNA Arrays to Identify MDSC Functional Pathways and Markers
使用 Micro-RNA 阵列识别 MDSC 功能途径和标记
- 批准号:
8601921 - 财政年份:2013
- 资助金额:
$ 18.81万 - 项目类别:
Inflammation and Prostate Cancer Development and Progression
炎症与前列腺癌的发生和进展
- 批准号:
8096809 - 财政年份:2010
- 资助金额:
$ 18.81万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment.
BPH/LUTS 药物治疗的长期有效性,并使用基于机器学习的预测分析来定制治疗。
- 批准号:
10283752 - 财政年份:2021
- 资助金额:
$ 18.81万 - 项目类别:
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment
BPH/LUTS 药物治疗的长期有效性,并使用基于机器学习的预测分析来定制治疗
- 批准号:
10618734 - 财政年份:2021
- 资助金额:
$ 18.81万 - 项目类别:
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
前列腺纤维化和下尿路功能障碍发展中的雌激素途径
- 批准号:
10597683 - 财政年份:2021
- 资助金额:
$ 18.81万 - 项目类别:
Estrogen pathways in the development of prostatic fibrosis and lower urinary tract dysfunction
前列腺纤维化和下尿路功能障碍发展中的雌激素途径
- 批准号:
10378476 - 财政年份:2021
- 资助金额:
$ 18.81万 - 项目类别:
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment
BPH/LUTS 药物治疗的长期有效性,并使用基于机器学习的预测分析来定制治疗
- 批准号:
10654038 - 财政年份:2021
- 资助金额:
$ 18.81万 - 项目类别: